What is the standard of care for locally advanced Prostate Cancer according to NCCN guidelines

Standard of Care for Locally Advanced Prostate Cancer (NCCN Guidelines)

Based on the NCCN Guidelines Version 2.2026 for Prostate Cancer, here's what constitutes standard care for locally advanced disease:

Initial Workup & Risk Assessment

Before treatment decisions, your care team should:

• Perform physical examination and digital rectal examination (DRE) to confirm clinical stage
• Measure PSA (prostate-specific antigen) levels
• Review diagnostic prostate biopsies to understand the cancer's characteristics
• Estimate life expectancy - this is crucial because treatment intensity depends partly on how long you're expected to live
• Assess for genetic factors - inquire about family history and consider genetic testing if appropriate
• Evaluate quality of life and discuss shared decision-making with your care team

Risk Stratification

Locally advanced prostate cancer falls into the high-risk or very-high-risk group category. According to NCCN Guidelines, your specific risk level determines treatment intensity. The guidelines emphasize that treatment should be more aggressive for high-risk and very-high-risk cancers.

Standard Treatment Approaches

For locally advanced disease, the NCCN Guidelines outline these general treatment pathways:

For patients choosing surgery:

• Radical prostatectomy (surgical removal of the prostate)
• Pelvic lymph node dissection (PLND) - a surgical procedure to remove and check lymph nodes in the pelvis for cancer spread
• Adjuvant therapy (additional treatment after surgery) may be recommended based on findings, which may include:
  • Radiation therapy to the prostate bed
  • Long-term hormone therapy (androgen deprivation therapy/ADT) to improve outcomes

For patients choosing radiation:

• External beam radiation therapy (EBRT) is a standard option
• May be combined with ADT (hormone therapy) depending on risk factors

Key Treatment Principles

According to NCCN Guidelines, the approach emphasizes:

• Combination therapy for high-risk disease - surgery or radiation is often combined with hormone therapy
• Individualized decision-making - your specific situation, preferences, and life expectancy guide which approach is best
• Shared decision-making - your care team should discuss pros and cons of each option with you

Important Questions to Ask Your Oncology Team

Since locally advanced prostate cancer requires personalized treatment planning, consider asking:

1. Based on my specific risk factors and staging, do you recommend surgery, radiation, or both?
2. If I choose surgery, will I need adjuvant radiation therapy or hormone therapy afterward?
3. What is my estimated life expectancy, and how does that influence treatment recommendations?
4. What are the potential side effects of each treatment option, and how might they affect my quality of life?
5. How will we monitor my PSA and imaging after treatment to detect any recurrence early?

Monitoring After Treatment

The NCCN Guidelines recommend ongoing monitoring with:

• PSA checks at regular intervals
• Imaging studies as clinically indicated
• Physical examination to assess for any signs of progression

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines Version 2.2026 for Prostate Cancer; NCCN Guidelines for Patients: Early-Stage and Advanced-Stage Prostate Cancer (2024)